Resources|Podcasts|March 28, 2025
Transformations in Drug Development for Cell and Gene Therapies
Author(s)PPD, Thermo Fisher Scientific
As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Related Content
Trending on Pharmaceutical Technology
1
Triple-Negative Breast Cancer Deal Signals Oncology Licensing Shift
2
What the OSTP’s New Policy Blueprint Means for Pharma Manufacturing and Development
3
Is Organizational Readiness Pharma's Real AI Barrier in 2026?
4
How to Maintain a Productive Sponsor-CMO Relationship
5